To further investigate the clinical relevance of REST and HAR1A/HAR1B expression, we compared the expression of these genes in a publicly available dataset of glioblastoma samples taken from MRI contrast enhancing (CE) tumour core and non-enhancing (NE) tumour periphery regions [17]. The gene discussed is HAR1A; the disease is neoplasm.